Research shows vaping tobacco-free nicotine e-liquid helps ADHD adult patients

While the medical community agrees that Attention Deficit Hyperactivity Disorder (ADHD) usually begins developing in childhood, millions of adults also suffer with this emotional disorder.  Statistics further indicate that about 60 percent of children diagnosed with ADHD will still be dealing with its negative effects well into adulthood.

However, scientists now believe that vaping tobacco-free nicotine e-liquids may help manage the severity of ADHA symptoms.  The use of transdermal applications and intravenous injections are also showing positive results.  To be clear, vaping for children as a therapeutic treatment is not only illegal but strongly discouraged by pediatric professionals.  In adults, the vast array of possible symptoms may include the following.

  • Trouble with organizational skills.
  • Lack of mental focus or concentration
  • Increases in reckless driving and/or traffic accidents
  • “Zoning out” and poor listening skills
  • Marital troubles
  • Easily distracted
  • Difficulty starting new tasks or procrastination
  • Habitual tardiness
  • Moodiness and occasional emotional outbursts
  • Mis-prioritizing important issues and tasks
  • Substance abuse
  • Anxiety attacks
  • Chronic or periodic bouts of depression

Related Article:  Dementia advocacy group to spend $9.4 million on nicotine therapy research

Adults patients with ADHD may have several of the above-listed symptoms.  They do not necessarily possess them all.   In 2001, research led by Dr. Ed Levin of the Department of Psychiatry at Duke University Medical Center in North Carolina published findings suggesting that nicotine therapies may help reduce a large number of the common symptomatic effects associated with ADHD.  The resulting paper entitled Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder is located in the U.S. National Library of Medicine National Institutes of Health (NCBI).

More research shows nicotine therapies reduce depression and anxiety in ADHD patients

In 2008, scientists from the Department of Nutritional Neuropsychiatry Southcoast Psychotherapy and Education Associates in Boca Raton, Florida, conducted nicotine research involving the dopaminergic, cholinergic and noradrenergic neurons of the brain in ADHD adults.  The researchers discovered that the use of transdermal nicotine patches as a medical therapy helps reduce symptoms of inattentiveness, memory impairment, depression, and anxiety.

Now over a decade later since the study was originally conducted, scientists also believe that vaping tobacco-free e-liquids works, too. Also published on the NCBI website, the study is entitled Transdermal Nicotine in Adult ADHD With Depression and Anxiety.

Related Article:  Research says vaping may increase lifespan of mental health patients by 20 years

(Image courtesy of Shutterstock)


Leave a comment

Please note, comments must be approved before they are published